Towards Healthcare Research & Consulting
U.S. Fertility Diagnostic Market
Updated Date: 15 June 2026   |   Report Code: 6949

U.S. Fertility Diagnostic Market Trends, Share and Growth Forecast

According to Shivani Zoting, who specializes in healthcare market diagnostics and healthcare industry analysis, with 5+ years of experience in market research and medical manufacturing studies, laboratory equipment, and medical devices indicate strong growth opportunities in the U.S. fertility diagnostic market. The market is projected to expand from USD 1.55 billion in 2026 to USD 3.33 billion by 2035, registering a CAGR of 8.9% during the forecast period. Her analysis highlights the increasing demand for IVF treatments, increasing infertility rates, and the rise of at-home and direct-to-consumer (DTC) testing in the region. The research highlights the shift toward preventive healthcare and research services, while underscoring Canada and Mexico as significant regional growth hubs. The studies also identify the competitive strategies of key industry participants, involving CooperSurgical, Femasys Inc., General Imaging Leaders, Genetic & Lab Testing Giants, and CCRM Fertility, shaping the future of fertility diagnostic and research services across the U.S.

Last Updated : 15 June 2026 Category: Diagnostics Insight Code: 6949 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

    • U.S. Fertility Diagnostic Market Analysis, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Fertility Diagnostic Market Analysis, By Test Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Fertility Diagnostic Market Analysis, By Mode of Testing, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Fertility Diagnostic Market Analysis, By Gender, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Fertility Diagnostic Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Fertility Diagnostic Market Analysis, By Distribution Channel, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Product Type
      • By Test Type
      • By Mode of Testing
      • By Gender
      • By End User
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • GE HealthCare
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Koninklijke Philips N.V.
    • Samsung Healthcare
    • CooperSurgical, Inc.
    • Femasys Inc.

FAQ's

Answer : The U.S. fertility diagnostic market size was estimated at USD 1.42 billion in 2025 and is predicted to increase from USD 1.55 billion in 2026 to approximately USD 3.33 billion by 2035, expanding at a CAGR of 8.9% from 2026 to 2035.

Answer : U.S. Fertility Diagnostic Market includes 5 segments By Product Type, By Test Type, By Mode of Testing, By Gender, By User

Answer : National Institutes of Health; FDA; WHO; PIB; CDC.

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar